On 26 March 2020, the President of the European Commission, Ursula von der Leyen and the President of the European Council, Charles Michel stated that “Europe stands ready to set up an international online pledging event to ensure adequate funding to develop and deploy a vaccine against COVID-19.” During an informal videoconference of 7 April 2020, Ministers responsible for research and innovation supported the first 10 priority actions of the first ERAvsCorona Action Plan which resulted from dialogues between the Commission services and the national ministries.1 It covers first short-term coordinated actions only. It sets out key measures the Commission services and the Member States are activating now to coordinate, share and jointly increase support for research & innovation, in line with the objectives and tools of the European Research Area.
10 priority actions for coordinated research and innovation actions:
- Coordination of R&I funding against the Coronavirus
- Extending and supporting large EU wide clinical trials for clinical management of Coronavirus patients
- New funding for innovative and rapid health-related approaches to respond to coronavirus and deliver quick results relevant to society and a higher level of preparedness of health systems
- Increasing support to innovative companies
- Creating opportunities for other funding sources to contribute to R&I actions on Coronavirus
- Establish a one-stop shop for Coronavirus R&I funding
- Establish an ad-hoc High Level R&I Task Force on the Coronavirus
- Access to Research Infrastructures
- Research data sharing platform
- Pan-EU Hackathon to mobilise European innovators and civil society (click the link to find out more)
Read the full document here.